The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, ...

A large-scale analysis has revealed independently validated gut biomarkers that can distinguish patients with inflammatory ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

A ginger compound, furanodienone (FDN), has been found to reduce inflammation and repair gut damage in IBD patients by ...

A new study published in BMC Gastroenterology identified that patients with inflammatory bowel disease (IBD), such as Crohn's ...

The mystery of why people with IBD are also at high risk from life-threatening blood clots has been solved by scientists at ...

Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

It wasn’t until a life-threatening emergency in 2023 that she was diagnosed with Ulcerative Colitis (UC), a form of ...

Sep. 23, 2020 — Inflammatory bowel disease (IBD), caused by chronic inflammation in the digestive tract linings, can be debilitating and life threatening. Therapeutic options include suppression ...

A study has shown how data, collected by wearable technology, can identify disease flare-ups up to seven weeks in advance.

The deal with Lilly is a crucial boost for Organovo, which ended last year with just $1.2 million in cash and nearly $350 million in debt. Organovo FXR is a clinical drug program focused on farnesoid ...